CYTOTOXICITY AND ANTIMICROBIAL ACTIVITY OF MONO-, DI- AND TRINUCLEAR RUTHENIUM(II) POLYPYRIDINE COMPLEXES
Keywords:
HepG2 cancer cells, Cytotoxicity, MTT assay, Antibacterial activity, Antifungal activity, Ruthenium polypyridyl complexesAbstract
Objectives: To evaluate the in vitro cytotoxicity, antibacterial and antifungal activity of the synthesized mono-, di- and trinuclear ruthenium(II) polypyridine complexes.
Methods: A series of synthesized ruthenium(II) complexes, R1, R2 and R3, are screened for in vitro antiproliferative activity against HepG2 cancer cell line using 96-well plate method. An assay of antimicrobial activity was performed by disc diffusion method. In addition an assay of an antifungal was performed by broth micro-dilution method.
Results: The cytotoxicity of complexes revealed IC50 values of 14.52 (R3), 19.53 (R2) and 22.32 μM (R1) against HepG2 cell line in a dose dependent manner. All the complexes inhibited moderately the growth of Gram positive bacteria (G+) such as Staphylococcus aureus (MRSA), Eubacterium lentum, and Bacillus subtillis, quite meagerly the growth of the Gram negative bacterium (G─), Enterobacter aerogenes, but did not inhibit at all the growth of Erwinia amylovora (MTCC 2760) and showed a slight antifungal activity.
Conclusion: From this study, we could suggest that the systematic increase in number of imidazole moiety along with expanding cloud of conjugated π-electron system of ruthenium(II) polypyridine complexes is responsible for the antiproliferative activity which increases in the order, R1 < R2 < R3 against HepG2 cancer cells. Consecutively, the complexes show good antimicrobial activity against Gram positive bacteria, but show poor or no effect against Gram negative bacteria and exhibit a little antifungal activity.
Â
Downloads
References
Carvalho MA, de Paiva REF, Bergamini FRG, Gomes AF, Gozzo FC, Lustri WR, et al. A silver complex with tryptophan: synthesis, structural characterization, DFT studies and antibacterial and antitumor assays in vitro. J Mol Struct 2013;1031:125-31.
Li F, Mulyana Y, Feterl M, Warner JM, Collins JG, Keene FR. The antimicrobial activity of inert oligonuclear polypyridylruthenium(II) complexes against pathogenic bacteria, including MRSA. Dalton Trans 2011;40:5032-8.
Mugge C, Liu R, Gorls H, Gabbiani C, Michelucci E, Rudiger N, et al. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions. Dalton Trans 2014;43:3072-86.
Gabano E, Ravera M, Osella D. Pros and cons of bifunctional platinum(IV) antitumor prodrugs: two are (not always) better than one. Dalton Trans 2014;43:9813-20.
Hartinger CG, Dyson PJ. Bioorganometallic chemistry-from teaching paradigms to medicinal applications. Chem Soc Rev 2009;38:391-401.
Farrer NJ, Salassa L, Sadler PJ. Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine. Dalton Trans 2009;10690-701.
Song H, Kaiser JT, Barton JK. Crystal structure of Δ-[Ru(bpy)2dppz]2+ bound to mismatched DNA reveals side-by-side metalloinsertion and intercalation. Nat Chem 2012;4:615-20.
Gorman BA, Francis PS, Barnett NW. Tris(2,2’-bipyridyl)ruthenium(II) chemiluminescence. Analyst 2006;131:616-39.
Galanski M, Arion VB, Jakupec MA, Keppler BK. Recent developments in the field of tumor-inhibiting metal complexes. Curr Pharm Des 2003;9:2078-89.
Sava G, Gagliardi R, Bergamo A, Alessio E, Mestroni G. Treatment of metastases of solid mouse tumours by NAMI-A: comparison with cisplatin, cyclophosphamide and dacarbazine. Anticancer Res 1979;19:969-72.
Li L, Cao W, Zheng W, Fan C, Chen T. Ruthenium complexes containing 2,6-bis(benzimidazolyl)pyridine derivatives induce cancer cell apoptosis by triggering DNA damage-mediated p53 phosphorylation. Dalton Trans 2012;41:12766-72.
Sánchez-González PD, López-Hernández FJ, López-Novoa JM, Morales AI. An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Crit Rev Toxicol 2011;41:803-21.
Bhhatarai B, Gramatica P. Per-and polyfluoro toxicity (LC50 Inhalation) study in rat and mouse using QSAR modeling. Chem Res Toxicol 2010;23:528-39.
Wong E, Giandomenico CM. Current status of platinum-based antitumor drugs. Chem Rev 1999;99:2451-66.
Farrell N. Platinum-based drugs in cancer therapy. Totowa (NJ): Humana Press; 2000.
Wheate NJ, Collins JG. Multi-nuclear platinum complexes as anti-cancer drugs. Coord Chem Rev 2003;241:133-45.
Richards AD, Rodger A, Hannon MJ, Bolhuis A. Antimicrobial activity of an iron triple helicate. Int J Antimicrobial Agents 2009;33:469-72.
Anthonysamy A, Balasubramanian S, Shanmugaiah V, Mathivanan N. Synthesis, characterization and electrochemistry of 4'-functionalized 2,2':6',2''-terpyridine ruthenium(II) complexes and their biological activity. Dalton Trans 2008;28(16):2136-43.
Ashwini Kumar K, Reddy KL, Vidhisha S, Satyanarayana S. Synthesis, characterization and DNA binding and photocleavage studies of [Ru(bpy)2 BDPPZ]2+, [Ru(dmb)2BDPPZ]2+ and [Ru(phen)2BDPPZ]2+ complexes and their antimicrobial activity. Appl Organomet Chem 2009;23:409-20.
Biersack B, Diestel R, Jagusch C, Sasse F, Schobert R. Metal complexes of natural melophlins and their cytotoxic and antibiotic activities. J Inorg Biochem 2009;103:72-6.
Bolhuis A, Hand L, Marshall JE, Richards AD, Rodger A, Aldrich-Wright J. Antimicrobial activity of ruthenium-based intercalators. Eur J Pharm Sci 2011;42:313-7.
Lam PL, Lu GL, Hon KM, Lee KW, Ho CL, Wang X, et al. Development of ruthenium(II) complexes as topical antibiotics against methicillin resistant Staphylococcus aureus. Dalton Trans 2014;43:3949-57.
Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol 1929;10:11.
Simmons KJ, Chopra I, Fishwick CW. Structure-based discovery of antibacterial drugs. Nat Rev Microbiol 2010;8:501-10.
Karageorgopoulos DE, Falagas ME. New antibiotics: optimal use in current clinical practice. Int J Antimicrob Agents 2009;34(Suppl 4):S55-S62.
Dwyer FP, Gyarfas EC, Rogers WP, Koch JH. Biological activity of complex ions. Nat 1952;170:90.
Dwyer FP, Gyarfas EC. J Proc R Soc N SW. 1949;83:171.
Howson SE, Bolhuis A, Brabec V, Clarkson GJ, Malina J, Rodger A, et al. Optically pure, water-stable metallo-helical ‘flexicate’ assemblies with antibiotic activity. Nat Chem 2012;4:31-6.
Kannan BS, Kumar DS. Synthesis and Characterization of mono-, di-and trinuclear Ruthenium(II) complexes. Int J Sci Eng Res 2014;5:84-9.
Swenson JM, Killgore GE, Tenover FC. Antimicrobial susceptibility testing of acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods. J Clin Microbiol 2004;42:5102-8.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
Tan C, Liu J, Chen L, Shi S, Ji L. Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes. J Inorg Biochem 2008;102:1644-53.
Drew WL, Barry AL, O'Toole R, Sherris JC. Reliability of the kirby-bauer disc diffusion method for detecting methicillin-resistant strains of staphylococcus aureus. Applied Microbiol 1972;24:240-7.
Chen Y, Qin M-Y, Wu J-H, Wang L, Chao H, Ji L-N, et al. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex. Eur J Med Chem 2013;70:120-9.
Salas JM, Angustias Romero M, Purificación Sánchez M, Quirós M. Metal complexes of [1,2,4]triazolo-[1,5-a]pyrimidine derivatives. Coord Chem Rev 1999;193–195:1119-42.
Haasnoot JG. Mononuclear, oligonuclear and polynuclear metal coordination compounds with 1,2,4-triazole derivatives as ligands. Coord Chem Rev 2000;200–202:131-85.
Rajendiran V, Murali M, Suresh E, Sinha S, Somasundaram K, Palaniandavar M. Mixed ligand ruthenium(II) complexes of bis(pyrid-2-yl)-/bis(benzimidazol-2-yl)-dithioether and diimines: Study of non-covalent DNA binding and cytotoxicity. Dalton Trans 2008;7(1):148-63.
Kalaivani P, Prabhakaran R, Dallemer F, Poornima P, Vaishnavi E, Ramachandran E, et al. DNA, protein binding, cytotoxicity, cellular uptake and antibacterial activities of new palladium(II) complexes of thiosemicarbazone ligands: effects of substitution on biological activity. Metallomics 2012;4:101-13.
Tan L, Shen J, Liu J, Zeng L, Jin L, Weng C. Spectral characteristics, DNA-binding and cytotoxicity of two functional Ru(II) mixed-ligand complexes. Dalton Trans 2012;41:4575-87.
Zheng X-H, Zhong Y-F, Tan C-P, Ji L-N, Mao Z-W. Pt(II) squares as selective and effective human telomeric G-quadruplex binders and potential cancer therapeutics. Dalton Trans 2012;41:11807-12.
Khan GS, Shah A, Ziaur R, Barker D. Chemistry of DNA minor groove binding agents. J Photochem Photobiol B: Biol 2012;115:105-18.
Simonetti G, Baffa S, Simonetti N. Contact imidazole activity against resistant bacteria and fungi. Int J Antimicrobial Agents 2001;17:389-93.
Tweedy BG. Plant extracts with metal ions as potential antimicrobial agents. Phytopathal 1964;55:8.
Anjaneyulu Y, Rao RP. Preparation, Characterization and antimicrobial activity studies on some ternary complexes of Cu(II) with acetylacetone and various salicylic acids. Syn React Inorg Metal-Org Chem 1986;16:257-72.
J Mann MJCC. Bacteria and antibacterial agents. Oxford (UK): Spectrum Academic Publishers; 1990.
PG Lawrence PLH, Francis OG. Antibiotic and chemotherapy. 4th ed. New York: Churchill Livingstone; 1973.
Koch AL. Bacterial wall as target for attack: Past, Present, and future research. Clini Microbiol Rev 2003;16:673-87.
El-Sherif AA. Synthesis, spectroscopic characterization and biological activity on newly synthesized copper(II) and nickel(II) complexes incorporating bidentate oxygen–nitrogen hydrazone ligands. Inorg Chim Acta 2009;362:4991-5000.